These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12350324)

  • 1. Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively.
    DeAngelis PL; Gunay NS; Toida T; Mao WJ; Linhardt RJ
    Carbohydr Res; 2002 Sep; 337(17):1547-52. PubMed ID: 12350324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a distinct, cryptic heparosan synthase from Pasteurella multocida types A, D, and F.
    Deangelis PL; White CL
    J Bacteriol; 2004 Dec; 186(24):8529-32. PubMed ID: 15576804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of the hyaluronic acid capsule of Pasteurella multocida.
    Guan L; Zhang L; Xue Y; Yang J; Zhao Z
    Microb Pathog; 2020 Dec; 149():104380. PubMed ID: 32645423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial glycosaminoglycan glycosyltransferases.
    DeAngelis PL
    Glycobiology; 2002 Jan; 12(1):9R-16R. PubMed ID: 11825882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F.
    DeAngelis PL; Padgett-McCue AJ
    J Biol Chem; 2000 Aug; 275(31):24124-9. PubMed ID: 10818104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D.
    DeAngelis PL; White CL
    J Biol Chem; 2002 Mar; 277(9):7209-13. PubMed ID: 11756462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presumptive identification of Pasteurella multocida serogroups A, D and F by capsule depolymerisation with mucopolysaccharidases.
    Rimler RB
    Vet Rec; 1994 Feb; 134(8):191-2. PubMed ID: 8171794
    [No Abstract]   [Full Text] [Related]  

  • 8. Capsular hyaluronic acid in Pasteurella multocida type A and its counterpart in type D.
    Pandit KK; Smith JE
    Res Vet Sci; 1993 Jan; 54(1):20-4. PubMed ID: 8434143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pasteurella multocida capsule: composition, function and genetics.
    Boyce JD; Chung JY; Adler B
    J Biotechnol; 2000 Sep; 83(1-2):153-60. PubMed ID: 11000471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis and regulation mechanisms of the Pasteurella multocida capsule.
    Guan L; Xue Y; Ding W; Zhao Z
    Res Vet Sci; 2019 Dec; 127():82-90. PubMed ID: 31678457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A capsule/lipopolysaccharide/MLST genotype D/L6/ST11 of Pasteurella multocida is likely to be strongly associated with swine respiratory disease in China.
    Peng Z; Wang H; Liang W; Chen Y; Tang X; Chen H; Wu B
    Arch Microbiol; 2018 Jan; 200(1):107-118. PubMed ID: 28825122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of Pasteurella multocida isolates from pigs with pneumonia in Korea.
    Kim J; Kim JW; Oh SI; So B; Kim WI; Kim HY
    BMC Vet Res; 2019 Apr; 15(1):119. PubMed ID: 31023320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of glycosaminoglycans and their glycosyltransferases: Implications for the extracellular matrices of animals and the capsules of pathogenic bacteria.
    DeAngelis PL
    Anat Rec; 2002 Nov; 268(3):317-26. PubMed ID: 12382327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of chondroitin sulfate and chondroitin.
    Schiraldi C; Cimini D; De Rosa M
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1209-20. PubMed ID: 20521042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Pasteurella multocida isolated from rabbits by capsular typing, somatic serotyping, and restriction endonuclease analysis.
    El Tayeb AB; Morishita TY; Angrick EJ
    J Vet Diagn Invest; 2004 Mar; 16(2):121-5. PubMed ID: 15053362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration that Australian Pasteurella multocida isolates from sporadic outbreaks of porcine pneumonia are non-toxigenic (toxA-) and display heterogeneous DNA restriction endonuclease profiles compared with toxigenic isolates from herds with progressive atrophic rhinitis.
    Djordjevic SP; Eamens GJ; Ha H; Walker MJ; Chin JC
    J Med Microbiol; 1998 Aug; 47(8):679-88. PubMed ID: 9877188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between capsular type and OmpA of Pasteurella multocida is associated with the outcome of disease.
    Verma S; Salwan R; Katoch S; Verma L; Chahota R; Dhar P; Sharma M
    Microb Pathog; 2016 Dec; 101():68-75. PubMed ID: 27838388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of bovine strains of Pasteurella multocida and comparison with isolates of avian, ovine and porcine origin.
    Davies RL; MacCorquodale R; Reilly S
    Vet Microbiol; 2004 Apr; 99(2):145-58. PubMed ID: 15019106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system.
    Townsend KM; Boyce JD; Chung JY; Frost AJ; Adler B
    J Clin Microbiol; 2001 Mar; 39(3):924-9. PubMed ID: 11230405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pasteurella multocida in backyard chickens in Upper Egypt: incidence with polymerase chain reaction analysis for capsule type, virulence in chicken embryos and antimicrobial resistance.
    Mohamed MA; Mohamed MW; Ahmed AI; Ibrahim AA; Ahmed MS
    Vet Ital; 2012; 48(1):77-86. PubMed ID: 22485004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.